Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0NEUVY
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
CN113286618A ADC-2
|
|||||
| Synonyms |
ADC-2
Click to Show/Hide
|
|||||
| Organization |
Medical Legal Person Foundation; Okayama University NUC
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
8.2
|
|||||
| Structure |
|
|||||
| Antibody Name |
alpha-KLHAb
|
Antibody Info | ||||
| Antigen Name |
Hemocyanin 1 (KLH1)
|
Antigen Info | ||||
| Payload Name |
Doxorubicin
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 2-alpha (TOP2A)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
CN113286618A-ADC-2-linker-doxorubicin
|
|||||